Trials / Unknown
UnknownNCT04541134
Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea
A Multi-center, Randomized, Placebo-controlled, Double-blind, Cross-over, Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 19 Years – 44 Years
- Healthy volunteers
- Not accepted
Summary
A Multi-center, Randomized, Placebo-controlled, Double-blind, Cross-over, Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients with Primary Dysmenorrhea
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pelubiprofen 45mg | Pelubiprofen 45mg 1 tab for moderate or severe menstrual pain, bid for 3days(prn) |
| DRUG | Placebo | Placebo1 tab for moderate or severe menstrual pain, bid for 3days(prn) |
Timeline
- Start date
- 2020-09-30
- Primary completion
- 2021-08-30
- Completion
- 2021-08-30
- First posted
- 2020-09-09
- Last updated
- 2020-09-09
Source: ClinicalTrials.gov record NCT04541134. Inclusion in this directory is not an endorsement.